Opthea Announces Upcoming Presentations at the Retina World Congress 2024 - Opthea (NASDAQ:OPT)
MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent